Capricor Therapeutics | CAPR - 当期純利益

株価
28.79
毎日の変更
-1.02 -3.42%
毎月
-16.77%
毎年
204.98%
Q2 予測
28.21




当期純利益 変化する 日付
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Bioline Rx USD -977K 2.96M 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 6.76B 6.75B 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Geron USD -3.64M 27.5M 2026-03
Grifols EUR 114.37M 34.03M 2025-12
Immunic USD -19.3M 6.28M 2025-12
J&J USD 5.24B 119M 2026-03
Plus Therapeutics USD -5.71M 1.29M 2025-12
Prothena USD -21.59M 14.95M 2025-12
PTC Therapeutics USD -2.81M 132.16M 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03